Last reviewed · How we verify
NCT03409406
Communication Outcomes for South African Children With Developmental Disabilities
NA trial testing Caregiver Intervention in Developmental Disability in 100 participants. Completed in 30 December 2019.
30 September 2019
Quick facts
| Lead sponsor | Georgia State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 July 2018 |
| Primary completion | 30 September 2019 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across South Africa |
Drugs / interventions tested
- Caregiver Intervention
- ST Intervention
Conditions studied
- Developmental Disability — all drugs for Developmental Disability →
Sponsor
Georgia State University
Who can join
Adults 3 to 6, any sex, with Developmental Disability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal is to remediate speech and language disorders early in the lives of South African children with significant developmental disorders (DD) by enhancing the health care service delivery system to better serve families across diverse backgrounds. This study assesses a new hybrid intervention to promote better communication skills for both the child and caregiver. The hybrid intervention includes a mobile health technology (MHT) web-based tablet protocol that assists parents/caregivers in communicating with their children on a daily basis at home over a 12-week period in addition to the current standard of care intervention, a 30-minute speech-language therapy session at the secondary/tertiary hospitals once a month. The hybrid intervention adds to the child's monthly therapy session by providing parents/caregivers with instruction about communication with their children via a sequenced web-based tablet protocol across a 12 week time period and face-to-face monthly follow-up at the hospital where the child receives therapy. Fifty parent/caregiver-child pairs (25 per group) will be assigned to either the hybrid intervention or the standard of care intervention. Child receptive and expressive language skills, child and parent/caregiver communication interactions and parent/caregiver and speech therapist satisfaction with child communication will be measured prior to the intervention and then again at the end of the 12-week period. The effects of the hybrid intervention and standard of care intervention on child communication skills, caregiver perception and satisfaction and speech therapist perception and satisfaction will be measured. The expectation is that the new MHT enhanced hybrid intervention program that is applicable and deliverable in culturally and linguistically diverse settings will enhance the child's receptive and expressive communication skills and result in greater parent/caregiver and speech therapist satisfaction related to the child. The impact includes enhanced health care service delivery to South African children with DD and their families so as to better serve the children with DD by remediating speech and language disorders on a daily basis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03409406
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Caregiver Intervention
Trials testing the same drug.
- NCT04581369 — Cirrhosis Medical Home · NA · completed
Other recruiting trials for Developmental Disability
Currently open trials in the same condition.
- NCT06764810 — Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Yea · recruiting
- NCT07176481 — Diné Parents Taking Action Trial · NA · active not recruiting
- NCT05987761 — PRT for Adolescents With High Functioning Autism · NA · recruiting
- NCT05201534 — Interventions in Mathematics and Cognitive Skills · NA · recruiting
- NCT05336955 — Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities · NA · recruiting
Other Georgia State University trials
Trials by the same sponsor.
- NCT07256275 — Peer Influences in Alcohol and Sexual Violence Among Marines Dyads · recruiting
- NCT06629428 — Effects of Ublituximab on Motor Functions in Multiple Sclerosis · EARLY_PHASE1 · recruiting
- NCT06787937 — Communicating About Nicotine Reduction in Cigarettes · NA · recruiting
- NCT06730646 — Testing Different Anti-smoking Messages Among Chinese Young Adult Smokers and Nonsmokers · NA · completed
- NCT06994624 — Clinical and Biochemical Effects of a Defined Plant-Based Diet on Heart Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03409406 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Georgia State University
- Last refreshed: 10 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03409406.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing